Britannia Life Sciences Inc. (CSE:BLAB)
Canada · Delayed Price · Currency is CAD 0.0700
0.00 (0.00%)
Oct 30, 2026, 10:45 AM EDT
Britannia Life Sciences Revenue
Britannia Life Sciences had revenue of 101.37K CAD in the quarter ending June 30, 2026, a decrease of -40.29%. This brings the company's total for the last twelve months to 406.44K, up 6.04% year-over-year. In the fiscal year ending March 31, 2026, Britannia Life Sciences had annual revenue of 474.83K with 28.58% growth. That makes Britannia Life Sciences the 45,111th largest company in the world by revenue and 999th in Canada.
Revenue (ttm)
406.44K
Revenue Growth
+6.04%
P/S Ratio
28.35
Revenue / Employee
n/a
Employees
28
Market Cap
11.52M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 474.83K | 105.56K | 28.58% |
| Mar 31, 2025 | 369.28K | -147.55K | -28.55% |
| Mar 31, 2024 | 516.83K | -5.89M | -91.93% |
| Mar 31, 2023 | 6.40M | -896.10K | -12.28% |
| Mar 31, 2022 | 7.30M | 5.88M | 412.42% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| COSCIENS Biopharma | 12.39M |
| Rapid Dose Therapeutics | 2.58M |
| Glow Lifetech | 2.31M |
| Pharmala Biotech Holdings | 1.27M |
| Onco-Innovations | 90.88K |
| Alzai Health | 69.09K |